Isabel Centeno | Oncology | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Isabel Centeno | Oncology | Research Excellence Award

Psycho-oncology | Tec Salud Medical Center | Mexico

Prof. Isabel Centeno is an accomplished researcher whose work focuses on evidence-based clinical research, systematic reviews, and outcome measurement in healthcare and oncology-related fields. Her scholarship emphasizes methodological rigor, patient-reported outcomes, and the translation of research evidence into clinical practice. She has authored 5 scholarly documents, receiving 44 citations across 44 documents, reflecting the relevance and impact of her work within the scientific community. Her research profile demonstrates a growing influence, with an h-index of 3; the View h-index button is disabled in preview mode.

Citation Metrics (Scopus)

50

40

30

20

10

0

Citations
44

Documents
5

h-index
3

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile

Featured Publications

Additional Scopus-indexed publication
– Details available via Scopus

Additional Scopus-indexed publication
– Details available via Scopus

Additional Scopus-indexed publication
– Details available via Scopus

Additional Scopus-indexed publication
– Details available via Scopus

omar alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Omar Alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Register Nurse at Al-Zaytoonah University of Jordan | Jordan

Mr. Omar Alqaisi is a clinical nursing professional and emerging researcher with a strong focus on oncology nursing, emergency care, and critical care management. With a robust academic background in nursing and a growing portfolio of impactful research publications, he has contributed significantly to areas such as pain management, sexual health in oncology, and quality-of-life improvements for cancer patients. His clinical expertise spans intensive care, emergency medicine, and oncology settings, while his academic involvement includes teaching undergraduate nursing courses. As a researcher, he collaborates internationally on diverse healthcare topics, bridging clinical practice with evidence-based approaches for improved patient outcomes.

Publication Profile 

Orcid

Education 

Mr. Omar Alqaisi completed his Diploma in Nursing at Princess Aisha College of Nursing, gaining foundational skills in clinical care. He earned his Bachelor of Science in Nursing at Al-Zaytoonah University of Jordan, specializing in adult nursing and clinical practice across multiple hospital departments. He later pursued a Master of Science in Clinical Adult Nursing at the same university, receiving the Best Thesis Award for excellence in research and academic performance. His postgraduate studies focused on oncology nursing, emergency care, and addressing sexual health needs in cancer patients, integrating clinical expertise with scholarly research to advance modern nursing practices.

Experience 

Mr. Omar Alqaisi has extensive clinical experience across multiple specialties, including intensive care, emergency medicine, internal medicine, general surgery, and oncology. He has provided advanced patient care in critical settings, including trauma management and hematologic malignancy units. Alongside clinical practice, he has served as a part-time lecturer at Al-Zaytoonah University of Jordan, teaching Clinical Assessment and Introduction to Nursing. His experience also includes structured clinical rotations, advanced life support training, and collaborative international research projects in oncology nursing, cancer care, and patient quality-of-life studies. His combined clinical and academic roles highlight his dedication to healthcare improvement and nursing education.

Awards and Honors 

Mr. Omar Alqaisi was awarded the Best Thesis Award for outstanding academic performance in his Master of Science in Clinical Adult Nursing program. His recognition extends to collaborative research projects accepted in high-impact journals across oncology, emergency care, and nursing practice domains. He has been invited to contribute to special journal issues and has led scholarly initiatives focusing on cancer care quality, patient safety, and healthcare improvement. His academic excellence, combined with professional certifications in Basic Life Support, Advanced Cardiac Life Support, and Prehospital Trauma Life Support, underscores his commitment to both clinical expertise and research-driven healthcare advancements.

Research Focus 

Mr. Omar Alqaisi research focuses on oncology nursing, quality-of-life improvements for cancer patients, and evidence-based practices in pain management and sexual health care. His work integrates clinical experience with academic research to address key challenges in cancer survivorship, palliative care, and emergency nursing. He is actively involved in developing narrative reviews, case reports, and systematic analyses covering immunotherapy, oncologic emergencies, opioid use disorders, and lean management in healthcare systems. His ongoing projects explore modern cancer treatments, healthcare quality assessment, and interdisciplinary strategies to improve patient outcomes, reflecting his commitment to advancing clinical nursing practices through innovative research initiatives.

Publication Top Notes

A Narrative Review of the Roles of Nursing in Addressing Sexual Dysfunction in Oncology Patients

Immunotherapy in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review

Oncology Nurses’ Attitudes, Knowledge, and Practices in Providing Sexuality Care to Cancer Patients: A Scoping Review

Quality of Postoperative Pain Management in Orthopedic Patients and Its Impact on Sleep Quality and Patient Satisfaction: An Integrative Review

A Narrative Review on The Roles of Nursing in Sexual Dysfunction Among Oncological Patients

Conclusion

Mr. Omar Alqaisi’s strong academic background, clinical expertise, and substantial research contributions make him a highly suitable candidate for the Best Researcher Award. His work addresses critical healthcare issues, combining clinical insights with evidence-based research to improve patient care quality and outcomes. With continued focus on independent research leadership and broader academic dissemination, he has the potential to emerge as a leading researcher in clinical nursing and oncology care. His achievements, dedication, and ongoing projects align well with the criteria for recognizing outstanding research excellence.

Alexis LeVee | Oncology Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Alexis LeVee | Oncology Pharmaceuticals | Best Researcher Award

Dr. Alexis LeVee at UCLA, United States.

Dr. A. LeVee is a physician-scientist specializing in medical oncology with a focus on breast cancer and translational immunotherapy. Currently a Clinical Instructor at UCLA and a Hematology/Oncology Fellow at City of Hope, Dr. LeVee combines clinical expertise with cutting-edge research in tumor immunology, the microbiome, and novel therapeutic biomarkers. A graduate of Duke University and Tufts Medical School, they are a recipient of multiple national awards, including the ASCO Conquer Cancer Young Investigator Award. With over 10 peer-reviewed publications and leadership in high-impact studies, Dr. LeVee is shaping the future of personalized cancer care and precision immunotherapy.

Publication Profile 

Google Scholar

Education

Dr. LeVee earned a B.A. in Chemistry with minors in Economics and Biology from Duke University (2013) 🧪, followed by an M.D. from Tufts University School of Medicine (2019) 🩺. They completed an Internal Medicine residency at Cedars-Sinai Medical Center (2019–2022) and are currently completing a Hematology/Medical Oncology Fellowship at City of Hope Comprehensive Cancer Center (2022–2025) 🧠. Their diverse training spans top-tier academic institutions and reflects a deep foundation in both clinical medicine and biomedical sciences, equipping them with the tools to integrate research and practice in complex oncology care.

Experience

Dr. LeVee currently serves as Clinical Instructor at UCLA (2025–Present) and Chief Fellow at City of Hope (2023–Present) in the Hematology/Medical Oncology Fellowship Program. Previously, they worked as a Business Analyst at Orange Advisory Group (2013–2015), combining data-driven insight with clinical research. Dr. LeVee has held numerous leadership and committee roles at Cedars-Sinai and City of Hope, contributing to medical education and institutional quality improvement. Their multidisciplinary background and academic leadership experience reflect a strong trajectory toward becoming a leader in translational oncology and academic medicine.

Awards 

Dr. LeVee has earned multiple prestigious awards, including the Young Investigator Award from ASCO, Conquer Cancer Foundation, and MOASC 🏆. Additional accolades include the Coltman Scholar Award and Early Investigator Award from the San Antonio Breast Cancer Symposium (2024), the ASCO Merit Award (2024), and finalist status for the Rubenstein Award for Resident Research (2022). Earlier honors include fellowships from Tufts, American Thoracic Society, and DukeEngage. These awards reflect their innovative research and impact in oncology, particularly in microbiome science, breast cancer immunotherapy, and biomarker discovery.

Research Focus 

Dr. LeVee’s research bridges clinical oncology and translational science, focusing on breast cancer, tumor microenvironment, and immunotherapy 🧬. Their work investigates how microbiota, immune signatures, and biomarkers predict treatment response in triple-negative and HER2+ breast cancers. With funding from ASCO, Biocodex, and City of Hope, Dr. LeVee leads multiple studies analyzing metagenomic and metatranscriptomic profiles of fecal microbiota in patients receiving chemoimmunotherapy. They also explore the cardiotoxic effects of cancer therapies and immuno-radiation synergy. Their goal is to develop precision tools that enhance treatment personalization and patient outcomes in cancer care.

Publication Top Notes